Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
BAFF maintains T-cell survival by inducing OPN expression in B cells.
No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and multiple sclerosis.
Four Promoters of IRF5 Respond Distinctly to Stimuli and are Affected by Autoimmune-Risk Polymorphisms.
[MELATONIN TREATMENT OF AUTOIMMUNE AND ALLERGIC PATHOLOGY].
Fatigue, Sleep Quality, and Disability in Relation to Quality of Life in Multiple Sclerosis.
Importance of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of the Treatment Efficacy in Multiple Sclerosis Patients with Acute Attacks.
Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis.
Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice.
Clinical pharmacology of ponesimod, a selective S1P1 receptor modulator, after uptitration to supratherapeutic doses in healthy subjects.
[Oculomotor system and multiple sclerosis.]
Adult-onset Krabbe disease presenting with an isolated form of peripheral neuropathy.
The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination.
Early diagnosis of Balo's concentric sclerosis by diffusion tensor tractography: a case report and literature review.
Correlation between blink reflex abnormalities and magnetic resonance imaging findings in patients with multiple sclerosis.
CLIPPERS-like MRI findings in a patient with multiple sclerosis.
G protein-coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration.
The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria.
Fingolimod therapy for multiple sclerosis.
CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.
Risk of fractures in patients with multiple sclerosis: A population-based cohort study.
[Analysis of clinical pathway in changing and disabling neurological diseases.]
Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome.
Analysis of the treatment of neuromyelitis optica.
Apcdd1 stimulates oligodendrocyte differentiation after white matter injury.
[A Case of Neuromyelitis Optica with Relapse Symptoms from Paroxysmal Pruritus].
Pages
« first
‹ previous
…
531
532
533
534
535
536
537
538
539
…
next ›
last »